1239279-19-6Relevant articles and documents
Asymmetric synthesis of an antagonist of neurokinin receptors: SSR 241586
Metro, Thomas-Xavier,Cochi, Anne,Gomez Pardo, Domingo,Cossy, Janine
, p. 2594 - 2602 (2011/06/20)
SSR 241586 is a 2,2-disubstituted morpholine, developed by Sanofi-Aventis, which is active in the treatment of schizophrenia and irritable bowel syndrome (IBS). Different strategies have been studied to synthesize this molecule and among the strategies an